Potential targets related to CHD were identified through KEGG pathway enrichment analysis, which included key pathways like the PI3K/Akt signaling cascade and EGFR tyrosine kinase inhibitor resistance mechanism. This evidence concerns the gene AKT1 and coronary artery disorder.